<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="drugs (doxorubicin, staurosporine and vandetanib) were tested on three human" exact="lung cancer" post="cell lines A549, HCC827 and NCI-H358. We tested compounds"/>
 <result pre="(doxorubicin, staurosporine and vandetanib) were tested on three human lung" exact="cancer" post="cell lines A549, HCC827 and NCI-H358. We tested compounds"/>
 <result pre="apoptotic activity ADME fig-count: table-count: page-count: word-count: 1. Introduction Lung" exact="cancer" post="is the second most common cancer (about 14%) of"/>
 <result pre="word-count: 1. Introduction Lung cancer is the second most common" exact="cancer" post="(about 14%) of new diagnosted cancers1. Although new drugs"/>
 <result pre="new diagnosted cancers1. Although new drugs and approaches to treating" exact="lung cancer" post="have been discovered in the last five years, chemotherapeutics"/>
 <result pre="diagnosted cancers1. Although new drugs and approaches to treating lung" exact="cancer" post="have been discovered in the last five years, chemotherapeutics"/>
 <result pre="still a medical need for new chemotherapeutics, primarily due to" exact="cancer" post="drug resistance and toxicity, which are the main therapy"/>
 <result pre="present the synthesis and preclinical screening inÂ vitro on human" exact="lung cancer" post="cells of novel amidino substituted benzimidazole/benzothiazole derivatives substituted with"/>
 <result pre="the synthesis and preclinical screening inÂ vitro on human lung" exact="cancer" post="cells of novel amidino substituted benzimidazole/benzothiazole derivatives substituted with"/>
 <result pre="culture) or 50â€‰ÂµM (3â€‰D cell culture). 2.2.1.1.2. Cell cultures Human" exact="lung cancer" post="cell lines A549 (ATCC CCL-185), HCC827 (ATCC CRL-2868) and"/>
 <result pre="or 50â€‰ÂµM (3â€‰D cell culture). 2.2.1.1.2. Cell cultures Human lung" exact="cancer" post="cell lines A549 (ATCC CCL-185), HCC827 (ATCC CRL-2868) and"/>
 <result pre="amidino substituted benzimidazole/benzothiazole derivatives 5aâ€&quot;5i and 6aâ€&quot;6g on three human" exact="lung cancer" post="cell lines A549, HCC827 and NCI-H358. As standard drugs,"/>
 <result pre="substituted benzimidazole/benzothiazole derivatives 5aâ€&quot;5i and 6aâ€&quot;6g on three human lung" exact="cancer" post="cell lines A549, HCC827 and NCI-H358. As standard drugs,"/>
 <result pre="2â€‰D cell assay we used a classic two-dimensional inÂ vitro" exact="cancer" post="cell line proliferation assay and as 3â€‰D assay we"/>
 <result pre="in 2â€‰D and 3â€‰D cell culture system for three human" exact="lung cancer" post="cell lines are depicted in Table 1. Table 1."/>
 <result pre="2â€‰D and 3â€‰D cell culture system for three human lung" exact="cancer" post="cell lines are depicted in Table 1. Table 1."/>
 <result pre="2â€‰D as well as in 3â€‰D assays against all three" exact="cancer" post="cells. Benzothiazole derivatives 5c and 5d show same or"/>
 <result pre="conflict of interest. References References 1BartaJA, PowellCA, WisniveskyJP.Global epidemiology of" exact="lung cancer." post="Ann Glob Health2019;85:8.30741509 2BansalY, SilakariO.The therapeutic journey of benzimidazoles:"/>
</results>
